215 Advanced Center for Treatment Research and Education in Cancer

Navi, India

215 Advanced Center for Treatment Research and Education in Cancer

Navi, India
SEARCH FILTERS
Time filter
Source Type

Telles E.,215 Advanced Center for Treatment Research and Education in Cancer | Gurjar M.,215 Advanced Center for Treatment Research and Education in Cancer | Ganti K.,215 Advanced Center for Treatment Research and Education in Cancer | Gupta D.,215 Advanced Center for Treatment Research and Education in Cancer | Dalal S.N.,215 Advanced Center for Treatment Research and Education in Cancer
Cell Cycle | Year: 2011

The activity of the dual specificity phosphatase cdc25C is required for mitotic progression though the mechanisms by which cdc25C is activated prior to mitosis in human cells remain unclear. The data presented herein show that the actin binding protein Filamin A forms a complex with cdc25C in vivo and binds preferentially to the mitotic form of cdc25C. Co-expression of Filamin A with cdc25C results in an increase in PCC induced by cdc25C, while knocking down Filamin A expression reduces the levels of PCC induced by cdc25C overexpression. Further, only a Filamin A fragment that forms a complex with both cdc25C and cyclin B1 and retains the dimerization domain can stimulate the ability of cdc25C to induce PCC. These results suggest that Filamin A provides a platform for the assembly of the cyclin B1-cdk1-cdc25C complex resulting in cdk1 activation and mitotic progression. © 2011 Landes Bioscience.


PubMed | 215 Advanced Center for Treatment Research and Education in Cancer
Type: Journal Article | Journal: Cell cycle (Georgetown, Tex.) | Year: 2011

The activity of the dual specificity phosphatase cdc25C is required for mitotic progression though the mechanisms by which cdc25C is activated prior to mitosis in human cells remain unclear. The data presented herein show that the actin binding protein Filamin A forms a complex with cdc25C in vivo and binds preferentially to the mitotic form of cdc25C. Co-expression of Filamin A with cdc25C results in an increase in PCC induced by cdc25C, while knocking down Filamin A expression reduces the levels of PCC induced by cdc25C overexpression. Further, only a Filamin A fragment that forms a complex with both cdc25C and cyclin B1 and retains the dimerization domain can stimulate the ability of cdc25C to induce PCC. These results suggest that Filamin A provides a platform for the assembly of the cyclin B1-cdk1- cdc25C complex resulting in cdk1 activation and mitotic progression.

Loading 215 Advanced Center for Treatment Research and Education in Cancer collaborators
Loading 215 Advanced Center for Treatment Research and Education in Cancer collaborators